324 related articles for article (PubMed ID: 26392508)
1. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase.
Kotsikorou E; Song Y; Chan JM; Faelens S; Tovian Z; Broderick E; Bakalara N; Docampo R; Oldfield E
J Med Chem; 2005 Sep; 48(19):6128-39. PubMed ID: 16162013
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei.
Loiseau PM; Gutierrez-Rios MT; De Frutos MI; Craciunescu DG
Parasitol Res; 2001 Jul; 87(7):566-9. PubMed ID: 11484855
[No Abstract] [Full Text] [Related]
4. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
Ott R; Chibale K; Anderson S; Chipeleme A; Chaudhuri M; Guerrah A; Colowick N; Hill GC
Acta Trop; 2006 Dec; 100(3):172-84. PubMed ID: 17126803
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.
Zhang Y; Cao R; Yin F; Hudock MP; Guo RT; Krysiak K; Mukherjee S; Gao YG; Robinson H; Song Y; No JH; Bergan K; Leon A; Cass L; Goddard A; Chang TK; Lin FY; Van Beek E; Papapoulos S; Wang AH; Kubo T; Ochi M; Mukkamala D; Oldfield E
J Am Chem Soc; 2009 Apr; 131(14):5153-62. PubMed ID: 19309137
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Development of Cycloguanil Derivatives as
Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
9. Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies.
Montalvetti A; Fernandez A; Sanders JM; Ghosh S; Van Brussel E; Oldfield E; Docampo R
J Biol Chem; 2003 May; 278(19):17075-83. PubMed ID: 12618430
[TBL] [Abstract][Full Text] [Related]
10. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
[TBL] [Abstract][Full Text] [Related]
11. Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site.
Liu YL; Lindert S; Zhu W; Wang K; McCammon JA; Oldfield E
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2530-9. PubMed ID: 24927548
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
[TBL] [Abstract][Full Text] [Related]
13. Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
Yin F; Cao R; Goddard A; Zhang Y; Oldfield E
J Am Chem Soc; 2006 Mar; 128(11):3524-5. PubMed ID: 16536518
[TBL] [Abstract][Full Text] [Related]
14. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors.
Zhang Z; Koh CY; Ranade RM; Shibata S; Gillespie JR; Hulverson MA; Huang W; Nguyen J; Pendem N; Gelb MH; Verlinde CL; Hol WG; Buckner FS; Fan E
ACS Infect Dis; 2016 Jun; 2(6):399-404. PubMed ID: 27627628
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
[TBL] [Abstract][Full Text] [Related]
17. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural analysis of AT-specific minor groove binders that disrupt DNA-protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast.
Millan CR; Acosta-Reyes FJ; Lagartera L; Ebiloma GU; Lemgruber L; Nué Martínez JJ; Saperas N; Dardonville C; de Koning HP; Campos JL
Nucleic Acids Res; 2017 Aug; 45(14):8378-8391. PubMed ID: 28637278
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity.
Eadsforth TC; Pinto A; Luciani R; Tamborini L; Cullia G; De Micheli C; Marinelli L; Cosconati S; Novellino E; Lo Presti L; Cordeiro da Silva A; Conti P; Hunter WN; Costi MP
J Med Chem; 2015 Oct; 58(20):7938-48. PubMed ID: 26322631
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
